These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 9572069

  • 1. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L, Güven O.
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E.
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [Abstract] [Full Text] [Related]

  • 8. Modulatory effects of the basolateral amygdala α2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze.
    Bashiri H, Rezayof A, Sahebgharani M, Tavangar SM, Zarrindast MR.
    Neuropharmacology; 2016 Jun; 105():478-486. PubMed ID: 26878830
    [Abstract] [Full Text] [Related]

  • 9. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R, Charieras T, Grosset A, Rovei V, Jarreau FX.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [Abstract] [Full Text] [Related]

  • 10. The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test.
    De Angelis L, Furlan C.
    Pharmacol Biochem Behav; 2000 Apr; 65(4):649-53. PubMed ID: 10764917
    [Abstract] [Full Text] [Related]

  • 11. Temporary inactivation of the rostral perirhinal cortex induces an anxiolytic-like effect on the elevated plus-maze and on the yohimbine-enhanced startle response.
    Schulz-Klaus B, Fendt M, Schnitzler HU.
    Behav Brain Res; 2005 Sep 08; 163(2):168-73. PubMed ID: 16029901
    [Abstract] [Full Text] [Related]

  • 12. Light-dark phase differences in behavioral effects of moclobemide in rats.
    Górka Z, Zajaczkowski W.
    Pol J Pharmacol Pharm; 1991 Sep 08; 43(3):177-86. PubMed ID: 1961692
    [Abstract] [Full Text] [Related]

  • 13. Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze tests.
    Pähkla R, Harro J, Rägo L.
    Pharmacol Res; 1996 Sep 08; 34(1-2):73-8. PubMed ID: 8981559
    [Abstract] [Full Text] [Related]

  • 14. Anxiogenic activity of intraventricularly administered bradykinin in rats.
    Bhattacharya SK, Mohan Rao PJ, Sen AP.
    J Psychopharmacol; 1995 Jan 08; 9(4):348-54. PubMed ID: 22298401
    [Abstract] [Full Text] [Related]

  • 15. Anxiogenic action of caffeine: an experimental study in rats.
    Bhattacharya SK, Satyan KS, Chakrabarti A.
    J Psychopharmacol; 1997 Jan 08; 11(3):219-24. PubMed ID: 9305413
    [Abstract] [Full Text] [Related]

  • 16. Use of the elevated T-maze to study anxiety in mice.
    Carvalho-Netto EF, Nunes-de-Souza RL.
    Behav Brain Res; 2004 Jan 05; 148(1-2):119-32. PubMed ID: 14684253
    [Abstract] [Full Text] [Related]

  • 17. Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl.
    Nowakowska E, Kus K, Chodera A, Rybakowski J.
    J Physiol Pharmacol; 2001 Dec 05; 52(4 Pt 2):863-73. PubMed ID: 11785779
    [Abstract] [Full Text] [Related]

  • 18. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M, Poltyrev T, Bejar C, Youdim MB.
    Psychopharmacology (Berl); 2002 Mar 05; 160(3):318-24. PubMed ID: 11889501
    [Abstract] [Full Text] [Related]

  • 19. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397
    [Abstract] [Full Text] [Related]

  • 20. Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats.
    Molina-Hernández M, Tellez-Alcántara NP, García JP, Lopez JI, Jaramillo MT.
    J Ethnopharmacol; 2004 Jul 14; 93(1):93-8. PubMed ID: 15182911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.